Evolus Inc. (NASDAQ:EOLS) went down by -10.58% from its latest closing price compared to the recent 1-year high of $14.81. The company’s stock price has collected 43.10% of gains in the last five trading sessions. Press Release reported on 02/19/21 that Evolus to Participate in the 10th Annual SVB Leerink Global Healthcare Conference
Is It Worth Investing in Evolus Inc. (NASDAQ :EOLS) Right Now?
Opinions of the stock are interesting as 5 analysts out of 8 who provided ratings for Evolus Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 2 rated it as “hold,” and 1 as “sell.”
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The average price from analysts is $13.50, which is -$1.32 below the current price. EOLS currently public float of 21.69M and currently shorts hold a 16.88% ratio of that float. Today, the average trading volume of EOLS was 1.39M shares.
EOLS’s Market Performance
EOLS stocks went up by 43.10% for the week, with a monthly jump of 89.48% and a quarterly performance of 234.04%, while its annual performance rate touched 7.43%. The volatility ratio for the week stands at 20.49% while the volatility levels for the past 30 days are set at 15.81% for Evolus Inc.. The simple moving average for the period of the last 20 days is 50.84% for EOLS stocks with a simple moving average of 151.98% for the last 200 days.
Analysts’ Opinion of EOLS
Many brokerage firms have already submitted their reports for EOLS stocks, with Mizuho repeating the rating for EOLS by listing it as a “Neutral.” The predicted price for EOLS in the upcoming period, according to Mizuho is $3 based on the research report published on July 07th of the previous year 2020.
SVB Leerink gave a rating of “Outperform” to EOLS, setting the target price at $25 in the report published on November 26th of the previous year.
EOLS Trading at 101.70% from the 50-Day Moving Average
After a stumble in the market that brought EOLS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -25.79% of loss for the given period.
Volatility was left at 15.81%, however, over the last 30 days, the volatility rate increased by 20.49%, as shares surge +66.01% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +187.70% upper at present.
During the last 5 trading sessions, EOLS rose by +43.10%, which changed the moving average for the period of 200-days by +157.38% in comparison to the 20-day moving average, which settled at $7.50. In addition, Evolus Inc. saw 227.08% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at EOLS starting from MOATAZEDI DAVID, who sale 8,310 shares at the price of $7.46 back on Jan 25. After this action, MOATAZEDI DAVID now owns 173,760 shares of Evolus Inc., valued at $61,993 using the latest closing price.
Avelar Rui, the See Remarks of Evolus Inc., sale 2,699 shares at $7.46 during a trade that took place back on Jan 25, which means that Avelar Rui is holding 134,103 shares at $20,135 based on the most recent closing price.
Stock Fundamentals for EOLS
Current profitability levels for the company are sitting at:
- -271.40 for the present operating margin
- +65.22 for the gross margin
The net margin for Evolus Inc. stands at -257.79. The total capital return value is set at -68.37, while invested capital returns managed to touch -65.22. Equity return is now at value -121.10, with -30.90 for asset returns.
Based on Evolus Inc. (EOLS), the company’s capital structure generated 121.51 points at debt to equity in total, while total debt to capital is 54.85. Total debt to assets is 40.15, with long-term debt to equity ratio resting at 120.00. Finally, the long-term debt to capital ratio is 54.17.
When we switch over and look at the enterprise to sales, we see a ratio of 8.89, with the company’s debt to enterprise value settled at 0.31. The receivables turnover for the company is 6.55 and the total asset turnover is 0.17. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.23.